MedPath

Effect of Ayurveda treatment in the Management of Tamaka Shwasa(Bronchial Asthma)

Phase 2
Conditions
Health Condition 1: J454- Moderate persistent asthma
Registration Number
CTRI/2022/07/044267
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Patients willing to participate and sign consent in the clinical trial.

•Patients in the age group of 18-65 yrs.

•Patients with Intermittent, mild-persistent & moderate-persistent asthma and are not on regular medication for Asthma.

•Patients having FEV1 > 60% of predicted value

•Patients of Rhinitis with spirometric evidence of reversible airflow obstruction.

•Patients who have not received any AYUSH intervention in last 15 days for related symptoms

Exclusion Criteria

•Patients having severe persistent (FEV1 <60 % of predicted) and Acute exacerbation of asthma

•Diagnosed cases of tuberculosis, pneumonia, COPD and other acute and chronic pulmonary disorders

•K/c/o malignancies of the respiratory and other system.

•Patients who have consumed AYUSH intervention for related complaints in last 15 days.

•Patients on regular anti allergic medications, on regular inhaled, intranasal or oral steroids.

•Patients on immunotherapy for allergy.

•Patients with Haemoglobin less than 9 mg/dl.

•Patients having concomitant systemic illness like uncontrolled Hypertension, Poorly controlled Diabetes Mellitus, Renal failure, Malignancy, Acute or Chronic liver disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢Forced Expiratory Volume in first second (FEV1) from baseline values.Timepoint: 56 days
Secondary Outcome Measures
NameTimeMethod
â?¢Improvement in Peak expiratory flow rate (PEFR). <br/ ><br>â?¢Changes in IgE & Absolute Eosinophil count <br/ ><br>â?¢Degree of improvement in asthma related symptoms on the basis of Asthma control questionnaire (ACQ) <br/ ><br>â?¢Degree of Improvement in Total Nasal Symptom Score (TNSS) <br/ ><br>Timepoint: 56 days
© Copyright 2025. All Rights Reserved by MedPath